Well-publicised controversies and damning media headlines over Alzheimer’s and oncology drugs have catapulted the National Institute for Health and Clinical Excellence (NICE) firmly into the public spotlight. Set up to remedy postcode prescribing, is NICE failing patients and wasting taxpayers’ money? The NICE dilemma: to treat or not to treat?
“Politics will lead you down many paths, but a conservative and a patriot will never be far from the Bow Group. Against the tide of globalism, liberalism, and Marxism the Bow Group stands resolute.
The Bow Group is where conservatism begins and ends in Britain, there is nowhere else like it.”
Ben Harris-Quinney, Bow Group Chairman
